CBP flagged Peter Daszak as a high person of interest over his gain-of-function research ties to the Wuhan Institute of ...

China's COVID-19 infection level has remained stable at a low level despite a recent uptick, and there is no need for the ...

China's COVID-19 epidemic remains at a low level despite a recent rise in test positivity rates at sentinel hospitals ...

Although the coronavirus—which once brought the entire world to a standstill—may no longer be the subject of intense ...

Lagging consumer spending and business investment offset the boost from strong exports thanks partly to the boom in ...

The risk of vector-borne diseases such as dengue fever and chikungunya fever is rising across China, while the overall ...

Official data showed gross domestic product in the world’s second-largest economy expanded 4.3% from a year ago in the ...

Growing shares of people see China favorably and have confidence in Xi Jinping, though opinions are much less positive in ...

The world has largely viewed the U.S. more favorably than China for years, but those opinions now have flipped in Beijing’s ...

Resurgence of COVID-19 Concerns The coronavirus, which once halted global activities, is no longer a hot topic of ...

Economic growth of 4.3 percent in the second quarter, versus the same period last year, reflected a broad slump outside of ...

For years, American policymakers, researchers, and security experts have warned the United States’s narrowing advantage in clinical research could threaten our dominance in medical innovation.